Fractyl Health, Inc. Common Stock

of this Current Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, a

Other Events. On January 5, 2026, the Company announced its strategic outlook for 2026, including anticipated clinical and regulatory milestones across its Revi

Financial Statements and Exhibits. The following exhibit relates to Item 2.02 and shall be deemed to be furnished, and not filed: Exhibit No. Description 99.1 P